Respiratory Allergies in India and Clinical Review of Montelukast Fexofenadine Combination in its Management Dr. Kamal Kant Kohli24 Sep 2022 6:27 AM GMTAllergic respiratory diseases (ARDs) are caused by the production of IgE antibodies to airborne allergens, causing various clinical manifestations in...
Managing Allergic Rhinitis: Why Combination Therapy Works? Dr. Kamal Kant Kohli7 Sep 2022 6:51 AM GMTAllergic Rhinitis (AR) is an IgE-mediated inflammation of the lining membranes of the nose caused by exposure to allergens. Mucosal inflammation is...
Allergic Rhinitis in Children: Practitioners Update and Consideration for Use of Intranasal Fluticasone Based Therapies Dr. Kamal Kant Kohli23 Aug 2022 7:15 AM GMTAllergic rhinitis (AR), an inflammatory disease caused by an IgE-mediated immune response to inhaled allergens, is a frequently occurring childhood...
Clarithromycin in outpatient ENT settings: A Review Dr. Kamal Kant Kohli2 Aug 2022 7:00 AM GMTIn outpatient care settings, otorhinolaryngologists and head and neck surgeons encounter many complex ears, nose, and throat (ENT) infectious...
Allergic rhinitis-an overview on treatment recommendations and current guidelines Dr. Kamal Kant Kohli22 July 2022 6:19 AM GMTRegarded to be an Ig-E mediated inflammatory disorder, most commonly affecting the nasal mucosa and its associated structures, Allergic Rhinitis (AR)...
Infographic: Allergic Rhinitis-Quick Overview of Treatment Algorithm Dr. Kamal Kant Kohli11 July 2022 7:15 AM GMTAllergic rhinitis (AR), an inflammatory illness of the upper respiratory tract, is now being acknowledged as a global health burden with estimates...
Management of Allergic Rhinitis during COVID-19 Pandemic Dr. Kamal Kant Kohli27 Jun 2022 6:30 AM GMTThe COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) has challenged the healthcare systems and altered the...
Bronchial Asthma - Early Indicators for Diagnosis and Its Management in Indian Practice Settings Dr. Kamal Kant Kohli17 Jun 2022 7:15 AM GMTBronchial Asthma-Indian PerspectiveAsthma is a chronic inflammatory airway disease associated with airway remodeling; augmenting its smooth muscle...
Managing co-existing allergic rhinitis and asthma: Analyzing the role of Montelukast-levocetirizine combination Dr. Kamal Kant Kohli13 Jun 2022 7:11 AM GMTAllergic rhinitis (AR) is now being acknowledged as a global health burden with estimates highlighting that 10%-25% of the population worldwide is...
Casirivimab/Imdevimab - An Indian Real World Experience : Review Dr. Kamal Kant Kohli10 Jun 2022 6:19 AM GMTThe antibody cocktail (Casirivimab and Imdevimab) has been approved in India for the treatment of mild to moderate COVID-19 in adolescents and adults...
Novel therapies in managing Allergic rhinitis: How far have we come? Dr. Kamal Kant Kohli8 Jun 2022 7:15 AM GMTAllergic rhinitis(AR) is a common respiratory condition affecting 40 % of the worldwide population. Due to its shared pathophysiology with...
Understanding the scope of Faropenem in Lower Respiratory Tract Infections(LRTIs) Dr. Kamal Kant Kohli1 Jun 2022 5:33 AM GMTLower Respiratory Infections(LRIs): Complexities in the Indian ContextIn India, the burden of lower respiratory tract infections (LRTIs) is...
